Introduction
Patients who have undergone renal transplantation are at considerable risk of lymphoproliferative disease, most commonly involving B lymphocytes, during the first year following transplantation. Although the exact incidence is not known precisely, the rate in these patients was reported to be 20 times higher than that in the general population [ 1 ] . There is strong evidence associating the Epstein-Barr virus (EBV) with the development of post-transplant lymphoproliferative disorders (PTLD). Extranodal involvement, often confined to the allograft, is a distinctive feature of PTLD. This report describes a case of EBV-associated B-cell lymphoma presenting as an extrinsic compression of the graft artery that produced an exacerbation of hypertension.
Case report
A 44-year-old woman with end-stage renal failure due to polycystic renal disease was placed on haemodialysis in May 1994 and underwent renal transplantation in November 1994 with a IB, 1DR matched cadaveric kidney. The donor was a 43-year-old woman who had died of cardiac arrest 1 month after valve replacement. The recipient's pre-transplantation EBV serology showed IgG against viral capsid antigen (VCA), negative VCA IgM and no IgG against nuclear antigen (EBNA). The donor had IgG antibodies against both VCA and EBNA, but the assay for IgM antibodies was negative. Immunosuppression consisted of induction with ALG and methylprednisolone for the first 14 days. Cyclosporin was introduced on the 8th day and the maintenance immunosuppressive treatment was cyclosporin plus prednisone. Graft function was recovered after an initial period of oliguria. The post-transplant course was not complicated by rejection episodes. Viral serology on days 11, 18 and 25 demonstrated transient IgM antibodies to EBV VCA which disappeared on day 31 without any increase in IgG titre. Intravenous acyclovir (600 mg/day) was given from days 9 to 28. When the patient was discharged on day 31, her serum creatinine was 146 umol/1 and her systolic and diastolic blood pressures were kept at 130/80mmHg with nicardipine and atenolol.
Seven weeks later she was readmitted with fever, cough, dyspnoea and hypoxaemia (PaO2 42 mmHg, PCO2 42 mmHg). Examination of bronchial washings disclosed Pneumocystis carinii. The patient was successfully treated with oxygen administered through a face mask, plus intravenous trimethoprim-sulphamethoxazole. The monthly ultrasound (US) and Doppler checks revealed some aliasing on colour mode and increased peak systolic velocities (2.5 m/s) on the midportion of the artery, indicating a mild stenosis, evaluated at 60%. The surrounding tissues were normal. These haemodynamic abnormalities remained stable for 4 months, but a retrospective study of the morphological patterns obtained in April showed a slight hypoechoic infiltration appearing around the artery which was initially not considered to be pathological.
The patient's blood pressure increased suddenly (180/100) in May 1995, and her weight increased by 2 kg, with a moderate serum increase in creatinine (172 umol/1). A monitoring by US control showed a tight stenosis (estimated at 85%) with very high peak systolic velocities (3.5 m/s). A 4 cm hypoechoic mass was then detected around the artery at the level of the stenosis ( Figure 1 ). There was no hydronephrosis. Angiography confirmed a tight, long stenosis with regular outlines and some neovascularization in the surrounding tissues and the hilum (Figure 2 ). Magnetic resonance imaging (MRI) gave a much clearer picture of the location and extent of the mass than did computed tomography (CT) because of its direct coronal slices and high contrast sequences (Figure 3) .
Cervical, chest, and abdominal CT scans showed no masses or adenopathy. There was no monoclonal gammapathy. Bone marrow aspiration revealed no abnormalities. The immunosuppressive treatment was stopped and transplant nephrectomy was performed in June 1995. Gross examination. The kidney measured 11 x 6 cm and had a well-defined lesion (4 x 3.6 x 2 cm) lesion in the hilar area. The cut surface of the tumour appeared soft, whitish, partially haemorrhagic, and necrotic. The tumour surrounded the allograft hilar artery, which was stenosed and had compressed the allograft hilar vein and the ureter. The kidney parenchyma was macroscopically healthy.
Light-microscopy. The tumour was made up of a polymorphic lymphoid proliferation that was focally necrosed. Large lymphoid non-cleaved cells predominated, with features compatible with immunoblasts. This large, partially necrosed lymphoid cell proliferation had invaded the adventitia the media and intima, which had arteriosclerotic fibrosis (Figure 4 ). The hilar vein was intact and the upper part of the ureter was infiltrated. This tumour was restricted to the hilum. The renal parenchyma contained a mild inflammatory chronic lymphocyte infiltration, which was mainly under the capsule, with foci of mild tubilitis without intimal arteritis. These lesions could be considered to be borderline changes. There was no lymphoproliferation in the renal parenchyma.
Immunochemistry. The proliferation consisted mainly of a lymphoid monoclonal B cell population with diffuse, intense reactivity towards leucocyte common antigen, MB2 and CD20, with lambda lightchain secretions. Some large B cells were stained with the EBV late membrane protein, and strong EBV genome expression was found in many cells by molecular hybridization. Cytogenetic features. A total of 10 metaphases was analysed and karyotyped. All the metaphases contained the same unaltered 46 XX.
These results confirmed the diagnosis of monoclonal B cell lymphoproliferation, its association with the Epstein-Barr virus, and its part in allograft artery stenosis. The patient is doing well 6 months after graft nephrectomy. She is on chronic haemodialysis and there is no evidence of lymphoma.
Discussion
Post-transplant lymphoproliferative disorder (PTLD) is a well-documented complication of kidney transplantation, but its exact incidence has not been accurately determined. The incidence seems to be higher in the USA than in Europe [1, 2] . The present report describes the fifth patient to develop PTLD in the 24 years history of our programme (726 patients). This incidence (0.6%) is similar to that reported recently by a UK group [2] .
Several factors contribute to the pathogenesis of PTLD in immunosuppressed patients, including impaired cellular immunity, chronic antigenic stimulation by the allograft and immunosuppressive agents, which may interfere with immune surveillance and allow transformed lymphocytes infected with EBV to grow without control by the immune system [3] . Although it is difficult to define the exact contribution of each individual agent, recent studies have implicated triple therapy with cyclosporin-azathioprine-prednisone [4] , prophylactic ATG [1] , and OKT3 [5, 6] . Our patient was induced with polyclonal ALG of the first 14 days, followed by maintenance treatment with steroids and cyclosporin.
PTLD is associated with EBV, which, as in our patient, has been demonstrated directly in the lymphoma cells [7] . The donor and the recipient both showed serological evidence of long-past infection at the time of transplantation. These features are consistent with results suggesting that EBV serology cannot be used to define the population at risk of developing lymphomas [8] . Nevertheless the recipient had an undetectable EBNA titre with a significant VCA titre. This serological response was also found in another of our patients with EBV-associated PTLD [9] . It may be due to a defect in an EBV specific cytotoxic T-cell population thought to be necessary for its release from the nuclear membrane of infected B cells, which then stimulates antibody production [7] . This anomaly could also facilitate the donor B-cell production after transplantation [10] . The exact origin of the tumour cells could not be documented, since both the donor and recipient were women and HLA typing of the cells was not performed.
Two clinical presentations of PTLD have been identified: (1) a diffuse form invading many organs, and (2) and a second that forms B-cell tumour masses [7] . The patient described here presented with limited renal allograft involvement, which has been reported in 20% of cases [11] . Several studies have reported ureteral obstruction with increase serum creatinine as the presenting sign [9, [12] [13] [14] [15] . This case is unique in that the location of the tumour in the renal hilum caused compression and infiltration of the transplant renal artery, leading to poorly controlled hypertension without hydronephrosis. It also illustrates an unusual but important potential pitfall in the imaging of renaltransplant complications. Ultrasound and Doppler techniques are considered to be good ways to detect and monitor a graft arterial stenosis [16] . Nevertheless, the Doppler patterns must always be correlated with grey-scale abnormalities to recognize the potential association of intrinsic and extrinsic factors as found in this case. MRI, with its fast imaging and postGadolinium sequences, appears to be more efficient than US or CT scans for evaluating the lymphoma mass and assessing its relationship with the iliac and transplant vessels [17] .
Therapy for EBV-associated lymphoproliferative disease remains a problem. Early diagnosis is imperative, since reduction or withdrawal of immunosuppression may lead to complete resolution of the disease, particularly when it is restricted to the allograft [3] .
